BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15960151)

  • 1. A case of gain-of-function mutation in calcium-sensing receptor: supplemental hydration is required for renal protection.
    Suzuki M; Aso T; Sato T; Michimata M; Kazama I; Saiki H; Hatano R; Ejima Y; Miyama N; Sato A; Matsubara M
    Clin Nephrol; 2005 Jun; 63(6):481-6. PubMed ID: 15960151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).
    Dong B; Endo I; Ohnishi Y; Kondo T; Hasegawa T; Amizuka N; Kiyonari H; Shioi G; Abe M; Fukumoto S; Matsumoto T
    J Bone Miner Res; 2015 Nov; 30(11):1980-93. PubMed ID: 25967373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel calcium-sensing receptor cytoplasmic tail deletion mutation causing autosomal dominant hypocalcemia: molecular and clinical study.
    Obermannova B; Sumnik Z; Dusatkova P; Cinek O; Grant M; Lebl J; Hendy GN
    Eur J Endocrinol; 2016 Apr; 174(4):K1-K11. PubMed ID: 26764418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene.
    Sato K; Hasegawa Y; Nakae J; Nanao K; Takahashi I; Tajima T; Shinohara N; Fujieda K
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3068-73. PubMed ID: 12107202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism.
    Hannan FM; Thakker RV
    Best Pract Res Clin Endocrinol Metab; 2013 Jun; 27(3):359-71. PubMed ID: 23856265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia.
    Kinoshita Y; Hori M; Taguchi M; Watanabe S; Fukumoto S
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E363-8. PubMed ID: 24297799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-sensing receptor residues with loss- and gain-of-function mutations are located in regions of conformational change and cause signalling bias.
    Gorvin CM; Frost M; Malinauskas T; Cranston T; Boon H; Siebold C; Jones EY; Hannan FM; Thakker RV
    Hum Mol Genet; 2018 Nov; 27(21):3720-3733. PubMed ID: 30052933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CASR gene activating mutations in two families with autosomal dominant hypocalcemia.
    Guarnieri V; Valentina D'Elia A; Baorda F; Pazienza V; Benegiamo G; Stanziale P; Copetti M; Battista C; Grimaldi F; Damante G; Pellegrini F; D'Agruma L; Zelante L; Carella M; Scillitani A
    Mol Genet Metab; 2012 Nov; 107(3):548-52. PubMed ID: 22789683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-sensing receptor sequencing in 21 patients with idiopathic or familial parathyroid disorder: pitfalls and characterization of a novel I32 V loss-of-function mutation.
    Szalat A; Shahar M; Shpitzen S; Nachmias B; Munter G; Gillis D; Durst R; Mevorach D; Leitersdorf E; Meiner V; Rosen H
    Endocrine; 2015 Mar; 48(2):444-53. PubMed ID: 25091521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A family of autosomal dominant hypocalcemia with an activating mutation of calcium-sensing receptor gene.
    Chikatsu N; Watanabe S; Takeuchi Y; Muraosa Y; Sasaki S; Oka Y; Fukumoto S; Fujita T
    Endocr J; 2003 Feb; 50(1):91-6. PubMed ID: 12733714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activating Calcium-Sensing Receptor Mutations: Prospects for Future Treatment with Calcilytics.
    Mayr B; Glaudo M; Schöfl C
    Trends Endocrinol Metab; 2016 Sep; 27(9):643-652. PubMed ID: 27339034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a G-Protein Subunit-α11 Gain-of-Function Mutation, Val340Met, in a Family With Autosomal Dominant Hypocalcemia Type 2 (ADH2).
    Piret SE; Gorvin CM; Pagnamenta AT; Howles SA; Cranston T; Rust N; Nesbit MA; Glaser B; Taylor JC; Buchs AE; Hannan FM; Thakker RV
    J Bone Miner Res; 2016 Jun; 31(6):1207-14. PubMed ID: 26818911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The calcium-sensing receptor and related diseases.
    D'Souza-Li L
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):628-39. PubMed ID: 17117288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation in the calcium-sensing receptor responsible for autosomal dominant hypocalcemia in a family with two uncommon parathyroid hormone polymorphisms.
    Alvarez-Hernández D; Santamaría I; Rodríguez-García M; Iglesias P; Delgado-Lillo R; Cannata-Andía JB
    J Mol Endocrinol; 2003 Oct; 31(2):255-62. PubMed ID: 14519094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of p.Arg205Cys in CASR in an autosomal dominant hypocalcaemia type 1 pedigree: A case report.
    Ji Y; Kang C; Chen J; Zhang L
    Medicine (Baltimore); 2021 Jun; 100(25):e26443. PubMed ID: 34160437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal dominant hypocalcemia with a novel
    Wu Y; Zhang C; Huang X; Cao L; Liu S; Zhong P
    J Int Med Res; 2022 Jul; 50(7):3000605221110489. PubMed ID: 35818129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium-sensing receptor and hypoparathyroidism].
    Michigami T
    Clin Calcium; 2007 Aug; 17(8):1186-91. PubMed ID: 17660614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Calcium-Sensing Receptor (CASR) Mutation in a Family with Autosomal Dominant Hypocalcemia Type 1 (ADH1): Genetic Study over Three Generations and Clinical Characteristics.
    Zung A; Barash G; Banne E; Levine MA
    Horm Res Paediatr; 2023; 96(5):473-482. PubMed ID: 36812896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A calcium-sensing receptor mutation causing hypocalcemia disrupts a transmembrane salt bridge to activate β-arrestin-biased signaling.
    Gorvin CM; Babinsky VN; Malinauskas T; Nissen PH; Schou AJ; Hanyaloglu AC; Siebold C; Jones EY; Hannan FM; Thakker RV
    Sci Signal; 2018 Feb; 11(518):. PubMed ID: 29463778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating Mutations of the G-protein Subunit α 11 Interdomain Interface Cause Autosomal Dominant Hypocalcemia Type 2.
    Gorvin CM; Stokes VJ; Boon H; Cranston T; Glück AK; Bahl S; Homfray T; Aung T; Shine B; Lines KE; Hannan FM; Thakker RV
    J Clin Endocrinol Metab; 2020 Mar; 105(3):952-63. PubMed ID: 31820785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.